 | Up a level |
Oechtering, Johanna; Stein, Kerstin; Schaedelin, Sabine A; Maceski, Aleksandra M; Orleth, Annette; Meier, Stephanie; Willemse, Eline; Qureshi, Ferhan; Heijnen, Ingmar; Regeniter, Axel; Derfuss, Tobias; Benkert, Pascal; D'Souza, Marcus; Limberg, Marguerite; Fischer-Barnicol, Bettina; Achtnichts, Lutz; Mueller, Stefanie; Salmen, Anke; Lalive, Patrice H; Bridel, Claire; ... (2024). Complement Activation Is Associated With Disease Severity in Multiple Sclerosis. Neurology: Neuroimmunology and Neuroinflammation, 11(2), e200212. Wolters Kluwer Health 10.1212/NXI.0000000000200212
Achtnichts, Lutz; Zecca, Chiara; Findling, Oliver; Kamm, Christian P; Mueller, Stefanie; Kuhle, Jens; Lutterotti, Andreas; Gobbi, Claudio; Viviani, Camille; Villiger-Borter, Emanuela; Nedeltchev, Krassen (2023). Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ neurology open, 5(1), e000304. British Medical Association 10.1136/bmjno-2022-000304
Disanto, Giulio; Benkert, Pascal; Lorscheider, Johannes; Mueller, Stefanie; Vehoff, Jochen; Zecca, Chiara; Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen; Radue, Ernst-Wilhelm; Sprenger, Till; Stippich, Christoph; Derfuss, Tobias; Louvion, Jean-François; Kamm, Christian Philipp; Mattle, Heinrich; Lotter, Christoph; Du Pasquier, Renaud; Schluep, Myriam; ... (2016). The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS ONE, 11(3), e0152347. Public Library of Science 10.1371/journal.pone.0152347
